Lazuna, Merlina .

HRN: 24-05-52  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/25/2024
CEFUROXIME 1.5GM (VIAL)
10/25/2024
10/26/2024
IV
1.5g
Ptor
Prophylaxis
Waiting Final Action 

 Indication:  Prophylaxis    Type of Infection:  Reproductive Tract    Compliance to guidelines: Compliant To Guidelines

 Final appropriateness: Yes     

 Overall appropriateness: Yes